Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

@article{Guyatt2012ApproachTO,
  title={Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.},
  author={Gordon H. Guyatt and John W. Eikelboom and Michael K Gould and David A Garcia and Mark Andrew Crowther and M Hassan Murad and Susan R. Kahn and Yngve T. Falck-Ytter and Charles W. Francis and Maarten Lansberg and Elie A. Akl and Jack Hirsh},
  journal={Chest},
  year={2012},
  volume={141 2 Suppl},
  pages={e185S-e194S}
}
This article provides the rationale for the approach to making recommendations primarily used in four articles of the Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines: orthopedic surgery, nonorthopedic surgery, nonsurgical patients, and stroke. Some of the early clinical trials of antithrombotic prophylaxis with a placebo or no treatment group used symptomatic VTE and fatal PE to measure efficacy of the… CONTINUE READING